Get the Stockscreener App
3.20
3.23%
0.10
After Hours:
3.13
-0.07
-2.19%
Sab Biotherapeutics Inc stock is traded at $3.20, with a volume of 140.86K.
It is up +3.23% in the last 24 hours and up +36.75% over the past month.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
See More
Previous Close:
$3.10
Open:
$2.98
24h Volume:
140.86K
Relative Volume:
0.61
Market Cap:
$33.32M
Revenue:
$114.70K
Net Income/Loss:
$-37.06M
P/E Ratio:
-0.8014
EPS:
-3.9929
Net Cash Flow:
$-30.69M
1W Performance:
-1.54%
1M Performance:
+36.75%
6M Performance:
+89.34%
1Y Performance:
-2.14%
1-Day Range:
$2.9638
$3.20
1-Week Range:
$2.842
$3.34
52-Week Range:
$1.00
$6.60
Sab Biotherapeutics Inc Stock (SABS) Company Profile
Name
Sab Biotherapeutics Inc
Sector
Industry
Phone
305-845-2813
Address
777 W 41ST ST, MIAMI BEACH
Compare SABS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SABS
Sab Biotherapeutics Inc
|
3.20 | 32.27M | 114.70K | -37.06M | -30.69M | -3.9929 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-17-25 | Initiated | Leerink Partners | Outperform |
| May-14-25 | Resumed | H.C. Wainwright | Buy |
| Oct-09-24 | Initiated | Craig Hallum | Buy |
| Aug-28-24 | Initiated | Oppenheimer | Outperform |
| Nov-05-21 | Initiated | Chardan Capital Markets | Buy |
Sab Biotherapeutics Inc Stock (SABS) Latest News
How SAB Biotherapeutics Inc. stock reacts to job market dataJuly 2025 Sector Moves & Verified Stock Trade Ideas - newser.com
Can SAB Biotherapeutics Inc. Equity Warrant stock resist sector downturns2025 Volume Leaders & Community Consensus Trade Signals - newser.com
Is SAB Biotherapeutics Inc. Equity Warrant a candidate for recovery playEarnings Risk Report & Community Verified Swing Trade Signals - newser.com
What sentiment indicators say about SAB Biotherapeutics Inc. stockJuly 2025 Weekly Recap & Accurate Buy Signal Notifications - newser.com
Ranking SAB Biotherapeutics Inc. Equity Warrant among high performing stocks via toolsMarket Weekly Review & Verified Entry Point Signals - newser.com
Trend analysis for SAB Biotherapeutics Inc. Equity Warrant this weekQuarterly Trade Report & Technical Entry and Exit Tips - newser.com
Can SAB Biotherapeutics Inc. Equity Warrant stock deliver surprise earnings beatMarket Performance Report & Reliable Breakout Forecasts - newser.com
Published on: 2025-11-07 09:57:09 - newser.com
Is SAB Biotherapeutics Inc. Equity Warrant reversing from oversold territoryJuly 2025 Outlook & Low Risk High Win Rate Picks - newser.com
Published on: 2025-11-07 09:13:38 - newser.com
Can trapped investors hope for a rebound in SAB Biotherapeutics Inc. Equity Warrant2025 Major Catalysts & Technical Entry and Exit Tips - newser.com
Will SAB Biotherapeutics Inc. stock maintain dividend yieldWeekly Gains Summary & Risk Adjusted Swing Trade Ideas - newser.com
What insider trading reveals about SAB Biotherapeutics Inc. Equity Warrant stockWeekly Trade Recap & High Conviction Investment Ideas - newser.com
Using data filters to optimize entry into SAB Biotherapeutics Inc. Equity WarrantWeekly Loss Report & Daily Chart Pattern Signal Reports - newser.com
Why SAB Biotherapeutics Inc. stock is trending among retail traders2025 Year in Review & Weekly Watchlist of Top Performers - fcp.pa.gov.br
Why SAB Biotherapeutics Inc. stock remains a top recommendation2025 Top Decliners & Low Risk High Win Rate Picks - fcp.pa.gov.br
Why SAB Biotherapeutics Inc. Equity Warrant stock remains undervaluedTrade Volume Summary & Real-Time Buy Zone Alerts - newser.com
Can trapped investors hope for a rebound in SAB Biotherapeutics Inc.2025 Price Momentum & Risk Controlled Daily Trade Plans - newser.com
Published on: 2025-11-06 05:14:04 - newser.com
Custom strategy builders for tracking SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com
Is SAB Biotherapeutics Inc. stock safe for conservative investorsWeekly Trade Summary & Verified Short-Term Trading Plans - newser.com
Why SAB Biotherapeutics Inc. Equity Warrant stock remains on buy listsJuly 2025 Sentiment & Fast Moving Stock Watchlists - newser.com
Can SAB Biotherapeutics Inc. stock outperform in 2025 bull market - fcp.pa.gov.br
Published on: 2025-11-06 03:56:19 - newser.com
Why SAB Biotherapeutics Inc. Equity Warrant stock is considered a top pick2025 Price Action Summary & Weekly High Return Forecasts - newser.com
Will SAB Biotherapeutics Inc. stock see PE expansionJuly 2025 Levels & Reliable Entry Point Alerts - newser.com
Using Bollinger Bands to evaluate SAB Biotherapeutics Inc. Equity Warrant2025 Support & Resistance & Fast Entry Momentum Alerts - newser.com
How SAB Biotherapeutics Inc. Equity Warrant stock performs in interest rate cyclesMarket Trend Summary & Risk Controlled Daily Trade Plans - newser.com
What hedge fund activity signals for SAB Biotherapeutics Inc. stock2025 Bull vs Bear & Verified Entry Point Signals - newser.com
Published on: 2025-11-06 02:17:17 - newser.com
How to build a custom watchlist for SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Sentiment & Risk Controlled Stock Pick Alerts - newser.com
How SAB Biotherapeutics Inc. Equity Warrant stock benefits from global expansionOptions Play & Consistent Profit Focused Trading Strategies - newser.com
Will SAB Biotherapeutics Inc. Equity Warrant stock benefit from sector rotation2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com
Published on: 2025-11-05 22:24:01 - newser.com
Will SAB Biotherapeutics Inc. stock deliver better than expected guidanceJuly 2025 PreEarnings & Growth Focused Entry Point Reports - newser.com
Using flow based indicators on SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Volume & Risk Managed Investment Signals - newser.com
Is SAB Biotherapeutics Inc. stock a contrarian buy2025 Geopolitical Influence & Smart Swing Trading Techniques - fcp.pa.gov.br
Quantitative breakdown of SAB Biotherapeutics Inc. Equity Warrant recent movePortfolio Gains Report & Safe Entry Zone Identification - newser.com
Custom strategy builders for tracking SAB Biotherapeutics Inc.July 2025 Short Interest & AI Enhanced Execution Alerts - newser.com
Will SAB Biotherapeutics Inc. stock deliver consistent dividendsJuly 2025 Breakouts & Weekly Setup with High ROI Potential - newser.com
Leading vs lagging indicators on SAB Biotherapeutics Inc. Equity Warrant performanceMarket Movement Recap & Smart Investment Allocation Tips - newser.com
Using Python tools to backtest SAB Biotherapeutics Inc. Equity Warrant strategies2025 Market Overview & Trade Opportunity Analysis Reports - newser.com
Sab Biotherapeutics Inc Stock (SABS) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):